Anti-EGFR Targeted Monoclonal Antibody Isotype Influences Antitumor Cellular Immunity in Head and Neck Cancer Patients. [electronic resource]
Producer: 20180116Description: 5229-5237 p. digitalISSN:- 1557-3265
- Antibodies, Monoclonal -- immunology
- CD8-Positive T-Lymphocytes -- drug effects
- Carcinoma, Squamous Cell -- drug therapy
- Cetuximab -- immunology
- Dendritic Cells -- drug effects
- ErbB Receptors -- antagonists & inhibitors
- Head and Neck Neoplasms -- drug therapy
- Humans
- Immunity, Cellular -- drug effects
- Immunoglobulin G -- immunology
- Killer Cells, Natural -- drug effects
- Monocytes -- drug effects
- Panitumumab
- Receptors, IgG -- immunology
- Squamous Cell Carcinoma of Head and Neck
- T-Lymphocytes, Cytotoxic -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.